Hatch/Waxman Incentives Could Make BTC Status A Win – Consultant
This article was originally published in The Tan Sheet
Executive Summary
Hatch/Waxman exclusivity protection should be expanded to encourage prescription to behind-the-counter switches under the existing two-class drug system, an industry consultant suggests